PRIAXON AG
Priaxon AG, based in Munich, Germany, discovers and develops small molecule therapeutics for novel target-ligand interactions. Proprietary, highly versatile chemo-informatics tools rapidly identify essential molecular determinants of novel target-ligand interactions, and apply this information to select suitable ligand motifs in previously unexplored chemical space. Our company goal is to demonstrate the superior efficiency in terms of innovation, timelines and R&D economics of applying Priaxon's tools to the rapid evaluation and NCE based exploitation of new drug targets.
PRIAXON AG
Industry:
Biotechnology
Founded:
2008-01-01
Address:
Munich, Bayern, Germany
Country:
Germany
Website Url:
http://www.priaxon.com
Total Employee:
1+
Status:
Active
Contact:
+498945213080
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
IPv6 Strato Strato DNS
Similar Organizations
Mitobridge
Mitobridge is discovering and developing small molecule therapeutics that improve mitochondrial functions.
NeuroNascent
Neuronascent discovers and develops small molecule therapeutics for depression and neurodegenerative diseases.
Investors List
Inveni Capital
Inveni Capital investment in Venture Round - Priaxon AG
Official Site Inspections
http://www.priaxon.com
- Host name: 104.21.75.16
- IP address: 104.21.75.16
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
